GATA3 and urothelial carcinoma: GATA3 is a marker of urothelial differentiation, expressed in 70% to 90% of urothelial carcinomas but is often lost in primary bladder adenocarcinomas (Figure 5), with the exception of signet-ring cell carcinoma of the urinary bladder.